← Leaderboards
Michele S. Redell
Baylor College Of Medicine
$3,028,784
Attributed
$3,028,784
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $405.8K · FY2008–21$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,028,784 · 3
By mechanism
R01$1,966,179 · 1
K08$640,860 · 1
R21$421,745 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Terzah M Horton$4,270,013
- David John Tweardy$14,168,425
- Troy R Torgerson$5,841,511
- Dolores Jean Lamb$15,622,235
- Timothy C Thompson$13,464,867
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyLeukemiaGene ExpressionResistanceCellsIn VivoMalignant NeoplasmsSignal TransductionResponseSignal PathwayPathway InteractionsIn VitroRelapseGrowth FactorPatternApoptosisStat3 ProteinPublishingGenesMolecular ProfilingDesignMyeloid CellsPreventBase
Grant awards (12)
High-Dimensional Profiling of Physiological Signaling Responses to Identify Relapse-Driving Cells in Acute Myeloid Leukemia$185,715
R21 · FY2021 · CA · contact PI
High-Dimensional Profiling of Physiological Signaling Responses to Identify Relapse-Driving Cells in Acute Myeloid Leukemia$236,030
R21 · FY2020 · CA · contact PI
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML$379,294
R01 · FY2018 · CA · contact PI
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML$379,294
R01 · FY2017 · CA · contact PI
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML$402,343
R01 · FY2016 · CA · contact PI
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML$399,401
R01 · FY2015 · CA · contact PI
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML$405,847
R01 · FY2014 · CA · contact PI
Stat3 Isoforms in Maturation and Survival of Normal and Malignant Myeloid Cells$128,172
K08 · FY2012 · HL · contact PI
Stat3 Isoforms in Maturation and Survival of Normal and Malignant Myeloid Cells$128,172
K08 · FY2011 · HL · contact PI
Stat3 Isoforms in Maturation and Survival of Normal and Malignant Myeloid Cells$128,172
K08 · FY2010 · HL · contact PI
Stat3 Isoforms in Maturation and Survival of Normal and Malignant Myeloid Cells$128,172
K08 · FY2009 · HL · contact PI
Stat3 Isoforms in Maturation and Survival of Normal and Malignant Myeloid Cells$128,172
K08 · FY2008 · HL · contact PI